新生児代謝スクリーニングの世界市場2023年:血液検査、尿検査

■ 英語タイトル:Global Newborn Metabolic Screening Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QYR23MA7513)■ 発行会社/調査会社:QYResearch
■ 商品コード:QYR23MA7513
■ 発行日:2023年3月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:99
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥440,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,350 ⇒換算¥661,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,800 ⇒換算¥881,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[新生児代謝スクリーニングの世界市場2023年:血液検査、尿検査]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査資料は新生児代謝スクリーニングのグローバル市場について調査・分析し、世界の新生児代謝スクリーニング市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析(血液検査、尿検査)、用途別セグメント分析(病院、専門クリニック、その他)、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、PerkinElmer、Bio-Rad Laboratories、Trivitron Healthcare Private Limited、BioMedomics, Inc.、Luminex Corporation、MP BIOMEDICALS、Synergy Medical Systems LLP、Agilent Technologies, Inc、Thermo Fisher Scientific, Inc、Zivak Technologies、Covidien Plc、AB Sciex LLC、Waters Corp.、Masimo Corp.、Natus Medical Inc.などが含まれています。新生児代謝スクリーニングのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。新型コロナとロシア・ウクライナ戦争の影響は、新生児代謝スクリーニング市場規模を算出する際に考慮しました。

・新生児代謝スクリーニング市場の概要
- 新生児代謝スクリーニングの種類別セグメント
- 世界の新生児代謝スクリーニング市場規模:タイプ別分析(血液検査、尿検査)
- 新生児代謝スクリーニングの用途別セグメント
- 世界の新生児代謝スクリーニング市場規模:用途別分析(病院、専門クリニック、その他)
- 世界の新生児代謝スクリーニング市場規模予測(2018年-2029年)

・新生児代謝スクリーニング市場の成長トレンド
- 新生児代謝スクリーニングの地域別市場規模(2018年-2029年)
- 新生児代謝スクリーニング市場ダイナミクス
- 新生児代謝スクリーニングの業界動向
- 新生児代謝スクリーニング市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M&A動向

・種類別セグメント:血液検査、尿検査
- 世界の新生児代謝スクリーニングのタイプ別市場規模(2018年-2023年)
- 世界の新生児代謝スクリーニングのタイプ別市場規模(2024年-2029年)

・用途別セグメント:病院、専門クリニック、その他
- 世界の新生児代謝スクリーニングの用途別市場規模(2018年-2023年)
- 世界の新生児代謝スクリーニングの用途別市場規模(2024年-2029年)

・新生児代謝スクリーニングの地域別市場規模
- 北米の新生児代謝スクリーニング市場規模(2018年-2029年)
- 米国の新生児代謝スクリーニング市場規模(2018年-2029年)
- ヨーロッパの新生児代謝スクリーニング市場規模(2018年-2029年)
- アジア太平洋の新生児代謝スクリーニング市場規模(2018年-2029年)
- 中国の新生児代謝スクリーニング市場規模(2018年-2029年)
- 日本の新生児代謝スクリーニング市場規模(2018年-2029年)
- 韓国の新生児代謝スクリーニング市場規模(2018年-2029年)
- インドの新生児代謝スクリーニング市場規模(2018年-2029年)
- オーストラリアの新生児代謝スクリーニング市場規模(2018年-2029年)
- 中南米の新生児代謝スクリーニング市場規模(2018年-2029年)
- 中東・アフリカの新生児代謝スクリーニング市場規模(2018年-2029年)

・主要企業のプロファイル:企業情報、事業概要、売上、動向
PerkinElmer、Bio-Rad Laboratories、Trivitron Healthcare Private Limited、BioMedomics, Inc.、Luminex Corporation、MP BIOMEDICALS、Synergy Medical Systems LLP、Agilent Technologies, Inc、Thermo Fisher Scientific, Inc、Zivak Technologies、Covidien Plc、AB Sciex LLC、Waters Corp.、Masimo Corp.、Natus Medical Inc.

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Newborn Metabolic Screening market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Newborn Metabolic Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Newborn Metabolic Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Newborn Metabolic Screening in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Newborn Metabolic Screening include PerkinElmer, Bio-Rad Laboratories, Trivitron Healthcare Private Limited, BioMedomics, Inc., Luminex Corporation, MP BIOMEDICALS, Synergy Medical Systems LLP, Agilent Technologies, Inc and Thermo Fisher Scientific, Inc, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Newborn Metabolic Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Metabolic Screening.
The Newborn Metabolic Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Newborn Metabolic Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Metabolic Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
PerkinElmer
Bio-Rad Laboratories
Trivitron Healthcare Private Limited
BioMedomics, Inc.
Luminex Corporation
MP BIOMEDICALS
Synergy Medical Systems LLP
Agilent Technologies, Inc
Thermo Fisher Scientific, Inc
Zivak Technologies
Covidien Plc
AB Sciex LLC
Waters Corp.
Masimo Corp.
Natus Medical Inc.
Segment by Type
Blood Test
Urine Test
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Metabolic Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次(コンテンツ)***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Metabolic Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood Test
1.2.3 Urine Test
1.3 Market by Application
1.3.1 Global Newborn Metabolic Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Metabolic Screening Market Perspective (2018-2029)
2.2 Newborn Metabolic Screening Growth Trends by Region
2.2.1 Global Newborn Metabolic Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Newborn Metabolic Screening Historic Market Size by Region (2018-2023)
2.2.3 Newborn Metabolic Screening Forecasted Market Size by Region (2024-2029)
2.3 Newborn Metabolic Screening Market Dynamics
2.3.1 Newborn Metabolic Screening Industry Trends
2.3.2 Newborn Metabolic Screening Market Drivers
2.3.3 Newborn Metabolic Screening Market Challenges
2.3.4 Newborn Metabolic Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Metabolic Screening Players by Revenue
3.1.1 Global Top Newborn Metabolic Screening Players by Revenue (2018-2023)
3.1.2 Global Newborn Metabolic Screening Revenue Market Share by Players (2018-2023)
3.2 Global Newborn Metabolic Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Newborn Metabolic Screening Revenue
3.4 Global Newborn Metabolic Screening Market Concentration Ratio
3.4.1 Global Newborn Metabolic Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Metabolic Screening Revenue in 2022
3.5 Newborn Metabolic Screening Key Players Head office and Area Served
3.6 Key Players Newborn Metabolic Screening Product Solution and Service
3.7 Date of Enter into Newborn Metabolic Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Metabolic Screening Breakdown Data by Type
4.1 Global Newborn Metabolic Screening Historic Market Size by Type (2018-2023)
4.2 Global Newborn Metabolic Screening Forecasted Market Size by Type (2024-2029)
5 Newborn Metabolic Screening Breakdown Data by Application
5.1 Global Newborn Metabolic Screening Historic Market Size by Application (2018-2023)
5.2 Global Newborn Metabolic Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Newborn Metabolic Screening Market Size (2018-2029)
6.2 North America Newborn Metabolic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Newborn Metabolic Screening Market Size by Country (2018-2023)
6.4 North America Newborn Metabolic Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Metabolic Screening Market Size (2018-2029)
7.2 Europe Newborn Metabolic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Newborn Metabolic Screening Market Size by Country (2018-2023)
7.4 Europe Newborn Metabolic Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Metabolic Screening Market Size (2018-2029)
8.2 Asia-Pacific Newborn Metabolic Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Newborn Metabolic Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Newborn Metabolic Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Metabolic Screening Market Size (2018-2029)
9.2 Latin America Newborn Metabolic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Newborn Metabolic Screening Market Size by Country (2018-2023)
9.4 Latin America Newborn Metabolic Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Metabolic Screening Market Size (2018-2029)
10.2 Middle East & Africa Newborn Metabolic Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Newborn Metabolic Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Newborn Metabolic Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Detail
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer Newborn Metabolic Screening Introduction
11.1.4 PerkinElmer Revenue in Newborn Metabolic Screening Business (2018-2023)
11.1.5 PerkinElmer Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Newborn Metabolic Screening Introduction
11.2.4 Bio-Rad Laboratories Revenue in Newborn Metabolic Screening Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Trivitron Healthcare Private Limited
11.3.1 Trivitron Healthcare Private Limited Company Detail
11.3.2 Trivitron Healthcare Private Limited Business Overview
11.3.3 Trivitron Healthcare Private Limited Newborn Metabolic Screening Introduction
11.3.4 Trivitron Healthcare Private Limited Revenue in Newborn Metabolic Screening Business (2018-2023)
11.3.5 Trivitron Healthcare Private Limited Recent Development
11.4 BioMedomics, Inc.
11.4.1 BioMedomics, Inc. Company Detail
11.4.2 BioMedomics, Inc. Business Overview
11.4.3 BioMedomics, Inc. Newborn Metabolic Screening Introduction
11.4.4 BioMedomics, Inc. Revenue in Newborn Metabolic Screening Business (2018-2023)
11.4.5 BioMedomics, Inc. Recent Development
11.5 Luminex Corporation
11.5.1 Luminex Corporation Company Detail
11.5.2 Luminex Corporation Business Overview
11.5.3 Luminex Corporation Newborn Metabolic Screening Introduction
11.5.4 Luminex Corporation Revenue in Newborn Metabolic Screening Business (2018-2023)
11.5.5 Luminex Corporation Recent Development
11.6 MP BIOMEDICALS
11.6.1 MP BIOMEDICALS Company Detail
11.6.2 MP BIOMEDICALS Business Overview
11.6.3 MP BIOMEDICALS Newborn Metabolic Screening Introduction
11.6.4 MP BIOMEDICALS Revenue in Newborn Metabolic Screening Business (2018-2023)
11.6.5 MP BIOMEDICALS Recent Development
11.7 Synergy Medical Systems LLP
11.7.1 Synergy Medical Systems LLP Company Detail
11.7.2 Synergy Medical Systems LLP Business Overview
11.7.3 Synergy Medical Systems LLP Newborn Metabolic Screening Introduction
11.7.4 Synergy Medical Systems LLP Revenue in Newborn Metabolic Screening Business (2018-2023)
11.7.5 Synergy Medical Systems LLP Recent Development
11.8 Agilent Technologies, Inc
11.8.1 Agilent Technologies, Inc Company Detail
11.8.2 Agilent Technologies, Inc Business Overview
11.8.3 Agilent Technologies, Inc Newborn Metabolic Screening Introduction
11.8.4 Agilent Technologies, Inc Revenue in Newborn Metabolic Screening Business (2018-2023)
11.8.5 Agilent Technologies, Inc Recent Development
11.9 Thermo Fisher Scientific, Inc
11.9.1 Thermo Fisher Scientific, Inc Company Detail
11.9.2 Thermo Fisher Scientific, Inc Business Overview
11.9.3 Thermo Fisher Scientific, Inc Newborn Metabolic Screening Introduction
11.9.4 Thermo Fisher Scientific, Inc Revenue in Newborn Metabolic Screening Business (2018-2023)
11.9.5 Thermo Fisher Scientific, Inc Recent Development
11.10 Zivak Technologies
11.10.1 Zivak Technologies Company Detail
11.10.2 Zivak Technologies Business Overview
11.10.3 Zivak Technologies Newborn Metabolic Screening Introduction
11.10.4 Zivak Technologies Revenue in Newborn Metabolic Screening Business (2018-2023)
11.10.5 Zivak Technologies Recent Development
11.11 Covidien Plc
11.11.1 Covidien Plc Company Detail
11.11.2 Covidien Plc Business Overview
11.11.3 Covidien Plc Newborn Metabolic Screening Introduction
11.11.4 Covidien Plc Revenue in Newborn Metabolic Screening Business (2018-2023)
11.11.5 Covidien Plc Recent Development
11.12 AB Sciex LLC
11.12.1 AB Sciex LLC Company Detail
11.12.2 AB Sciex LLC Business Overview
11.12.3 AB Sciex LLC Newborn Metabolic Screening Introduction
11.12.4 AB Sciex LLC Revenue in Newborn Metabolic Screening Business (2018-2023)
11.12.5 AB Sciex LLC Recent Development
11.13 Waters Corp.
11.13.1 Waters Corp. Company Detail
11.13.2 Waters Corp. Business Overview
11.13.3 Waters Corp. Newborn Metabolic Screening Introduction
11.13.4 Waters Corp. Revenue in Newborn Metabolic Screening Business (2018-2023)
11.13.5 Waters Corp. Recent Development
11.14 Masimo Corp.
11.14.1 Masimo Corp. Company Detail
11.14.2 Masimo Corp. Business Overview
11.14.3 Masimo Corp. Newborn Metabolic Screening Introduction
11.14.4 Masimo Corp. Revenue in Newborn Metabolic Screening Business (2018-2023)
11.14.5 Masimo Corp. Recent Development
11.15 Natus Medical Inc.
11.15.1 Natus Medical Inc. Company Detail
11.15.2 Natus Medical Inc. Business Overview
11.15.3 Natus Medical Inc. Newborn Metabolic Screening Introduction
11.15.4 Natus Medical Inc. Revenue in Newborn Metabolic Screening Business (2018-2023)
11.15.5 Natus Medical Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Newborn Metabolic Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Blood Test
Table 3. Key Players of Urine Test
Table 4. Global Newborn Metabolic Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Newborn Metabolic Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Newborn Metabolic Screening Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Newborn Metabolic Screening Market Share by Region (2018-2023)
Table 8. Global Newborn Metabolic Screening Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Newborn Metabolic Screening Market Share by Region (2024-2029)
Table 10. Newborn Metabolic Screening Market Trends
Table 11. Newborn Metabolic Screening Market Drivers
Table 12. Newborn Metabolic Screening Market Challenges
Table 13. Newborn Metabolic Screening Market Restraints
Table 14. Global Newborn Metabolic Screening Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Newborn Metabolic Screening Market Share by Players (2018-2023)
Table 16. Global Top Newborn Metabolic Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Metabolic Screening as of 2022)
Table 17. Ranking of Global Top Newborn Metabolic Screening Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Newborn Metabolic Screening Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Newborn Metabolic Screening Product Solution and Service
Table 21. Date of Enter into Newborn Metabolic Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Newborn Metabolic Screening Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Newborn Metabolic Screening Revenue Market Share by Type (2018-2023)
Table 25. Global Newborn Metabolic Screening Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Newborn Metabolic Screening Revenue Market Share by Type (2024-2029)
Table 27. Global Newborn Metabolic Screening Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Newborn Metabolic Screening Revenue Market Share by Application (2018-2023)
Table 29. Global Newborn Metabolic Screening Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Newborn Metabolic Screening Revenue Market Share by Application (2024-2029)
Table 31. North America Newborn Metabolic Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Newborn Metabolic Screening Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Newborn Metabolic Screening Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Newborn Metabolic Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Newborn Metabolic Screening Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Newborn Metabolic Screening Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Newborn Metabolic Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Newborn Metabolic Screening Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Newborn Metabolic Screening Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Newborn Metabolic Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Newborn Metabolic Screening Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Newborn Metabolic Screening Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Newborn Metabolic Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Newborn Metabolic Screening Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Newborn Metabolic Screening Market Size by Country (2024-2029) & (US$ Million)
Table 46. PerkinElmer Company Detail
Table 47. PerkinElmer Business Overview
Table 48. PerkinElmer Newborn Metabolic Screening Product
Table 49. PerkinElmer Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 50. PerkinElmer Recent Development
Table 51. Bio-Rad Laboratories Company Detail
Table 52. Bio-Rad Laboratories Business Overview
Table 53. Bio-Rad Laboratories Newborn Metabolic Screening Product
Table 54. Bio-Rad Laboratories Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 55. Bio-Rad Laboratories Recent Development
Table 56. Trivitron Healthcare Private Limited Company Detail
Table 57. Trivitron Healthcare Private Limited Business Overview
Table 58. Trivitron Healthcare Private Limited Newborn Metabolic Screening Product
Table 59. Trivitron Healthcare Private Limited Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 60. Trivitron Healthcare Private Limited Recent Development
Table 61. BioMedomics, Inc. Company Detail
Table 62. BioMedomics, Inc. Business Overview
Table 63. BioMedomics, Inc. Newborn Metabolic Screening Product
Table 64. BioMedomics, Inc. Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 65. BioMedomics, Inc. Recent Development
Table 66. Luminex Corporation Company Detail
Table 67. Luminex Corporation Business Overview
Table 68. Luminex Corporation Newborn Metabolic Screening Product
Table 69. Luminex Corporation Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 70. Luminex Corporation Recent Development
Table 71. MP BIOMEDICALS Company Detail
Table 72. MP BIOMEDICALS Business Overview
Table 73. MP BIOMEDICALS Newborn Metabolic Screening Product
Table 74. MP BIOMEDICALS Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 75. MP BIOMEDICALS Recent Development
Table 76. Synergy Medical Systems LLP Company Detail
Table 77. Synergy Medical Systems LLP Business Overview
Table 78. Synergy Medical Systems LLP Newborn Metabolic Screening Product
Table 79. Synergy Medical Systems LLP Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 80. Synergy Medical Systems LLP Recent Development
Table 81. Agilent Technologies, Inc Company Detail
Table 82. Agilent Technologies, Inc Business Overview
Table 83. Agilent Technologies, Inc Newborn Metabolic Screening Product
Table 84. Agilent Technologies, Inc Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 85. Agilent Technologies, Inc Recent Development
Table 86. Thermo Fisher Scientific, Inc Company Detail
Table 87. Thermo Fisher Scientific, Inc Business Overview
Table 88. Thermo Fisher Scientific, Inc Newborn Metabolic Screening Product
Table 89. Thermo Fisher Scientific, Inc Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 90. Thermo Fisher Scientific, Inc Recent Development
Table 91. Zivak Technologies Company Detail
Table 92. Zivak Technologies Business Overview
Table 93. Zivak Technologies Newborn Metabolic Screening Product
Table 94. Zivak Technologies Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 95. Zivak Technologies Recent Development
Table 96. Covidien Plc Company Detail
Table 97. Covidien Plc Business Overview
Table 98. Covidien Plc Newborn Metabolic Screening Product
Table 99. Covidien Plc Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 100. Covidien Plc Recent Development
Table 101. AB Sciex LLC Company Detail
Table 102. AB Sciex LLC Business Overview
Table 103. AB Sciex LLC Newborn Metabolic Screening Product
Table 104. AB Sciex LLC Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 105. AB Sciex LLC Recent Development
Table 106. Waters Corp. Company Detail
Table 107. Waters Corp. Business Overview
Table 108. Waters Corp. Newborn Metabolic Screening Product
Table 109. Waters Corp. Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 110. Waters Corp. Recent Development
Table 111. Masimo Corp. Company Detail
Table 112. Masimo Corp. Business Overview
Table 113. Masimo Corp. Newborn Metabolic Screening Product
Table 114. Masimo Corp. Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 115. Masimo Corp. Recent Development
Table 116. Natus Medical Inc. Company Detail
Table 117. Natus Medical Inc. Business Overview
Table 118. Natus Medical Inc. Newborn Metabolic Screening Product
Table 119. Natus Medical Inc. Revenue in Newborn Metabolic Screening Business (2018-2023) & (US$ Million)
Table 120. Natus Medical Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Newborn Metabolic Screening Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Newborn Metabolic Screening Market Share by Type: 2022 VS 2029
Figure 3. Blood Test Features
Figure 4. Urine Test Features
Figure 5. Global Newborn Metabolic Screening Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Newborn Metabolic Screening Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Specialty Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Newborn Metabolic Screening Report Years Considered
Figure 11. Global Newborn Metabolic Screening Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Newborn Metabolic Screening Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Newborn Metabolic Screening Market Share by Region: 2022 VS 2029
Figure 14. Global Newborn Metabolic Screening Market Share by Players in 2022
Figure 15. Global Top Newborn Metabolic Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Metabolic Screening as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Newborn Metabolic Screening Revenue in 2022
Figure 17. North America Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Newborn Metabolic Screening Market Share by Country (2018-2029)
Figure 19. United States Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Newborn Metabolic Screening Market Share by Country (2018-2029)
Figure 23. Germany Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Newborn Metabolic Screening Market Share by Region (2018-2029)
Figure 31. China Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Newborn Metabolic Screening Market Share by Country (2018-2029)
Figure 39. Mexico Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Newborn Metabolic Screening Market Share by Country (2018-2029)
Figure 43. Turkey Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Newborn Metabolic Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. PerkinElmer Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 46. Bio-Rad Laboratories Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 47. Trivitron Healthcare Private Limited Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 48. BioMedomics, Inc. Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 49. Luminex Corporation Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 50. MP BIOMEDICALS Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 51. Synergy Medical Systems LLP Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 52. Agilent Technologies, Inc Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 53. Thermo Fisher Scientific, Inc Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 54. Zivak Technologies Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 55. Covidien Plc Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 56. AB Sciex LLC Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 57. Waters Corp. Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 58. Masimo Corp. Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 59. Natus Medical Inc. Revenue Growth Rate in Newborn Metabolic Screening Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QYR23MA7513 )"新生児代謝スクリーニングの世界市場2023年:血液検査、尿検査" (英文:Global Newborn Metabolic Screening Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。